Article info
PDFCorrespondence
High risk of systemic lupus erythematosus development in patients with ITP: antiphospholipid syndrome is also a concern
- Correspondence to Dr Murat İnanç, Istanbul Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Istanbul University, Fatih 34390, Istanbul, Turkey; drinanc{at}istanbul.edu.tr
Citation
High risk of systemic lupus erythematosus development in patients with ITP: antiphospholipid syndrome is also a concern
Publication history
- Received June 19, 2020
- Accepted June 20, 2020
- First published August 21, 2020.
Online issue publication
October 18, 2023
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.